接种新冠灭活疫苗会导致肺结节吗？专业解读→

参考文献：

[1] 张晓菊, 白莉, 金发光, 等. 肺结节诊治中国专家共识(2018 年版)[J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.

[2] 吴建彬, 蒋磊, 徐国厚, 等. 9776 例健康体检人员肺结节 的 筛 查 状 况 及 危 险 因 素 的 探 讨 [J]. 医 学 理 论 与 实 践 , 2022, 35(14): 2496-2499.DOI:10.19381/j.issn.1001-7585.2022.14.066.

[3] 季明, 王媛慧, 周洁, 等. 教师体检人群肺结节检出结果及影响因素分析[J].现代肿瘤医学, 2022, 30(16): 2933-2937.

[4] 魏周阳, 刘政, 赵红梅, 等. 湘潭市某单位员工肺结节筛检情况及影响因素研究[J]. 华南预防医学, 2022, 48(02): 147-150+155.

[5] 中华医学会放射学分会心胸学组. 低剂量螺旋 CT 肺癌筛查专家共识[J].  中华放射学杂志, 2015(5): 328-335. DOI:10.3760/cma.j.issn.1005-1201.2015.05.003.2.

[6] Gao Q, Bao L, Qin C, et al. Development of an inactivated vaccine candidate for SARSCoV-2[J]. Science, 2020 Jul 3; 369(6499): 77-81. doi: 10.1126/science.abc1932. Epub 2020May 6. PMID: 32376603; PMCID: PMC7202686.

[7] Han B, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial[J]. Lancet Infect Dis, 2021, 12: 1645-1653.

[8] Wu Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, doubleblind, placebo-controlled, phase 1/2 clinical trial[J]. Lancet Infect Dis, 2021, 21(6): 803-812.

[9] Tanriover MD, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey[J]. Lancet, 2021, 398(10296): 213-222.

[10] WHO. Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine.